POA Pharma is now a Galen company

Galen, the privately owned global pharmaceutical sales and marketing company, is delighted to announce the acquisition and takeover of boutique healthcare company, POA Pharma.

New website coming soon

  • Salovum®


    Salovum® is a product based on egg yolk powder B221® , and is a source of protein AF. Antisecretory Factor (AF) is a protein that is naturally present in the body.

    Salovum® can be used in the acute phase or as the beginning treatment of patients with a presumed low amount of AF.

    Salovum® can normalize fluid flow. This is of clinical significance within bowel diseases, diarrhea, Mèniére and Mastitis.

    Salovum® has also been shown to have an anti-inflammatory effect which was seen in studies of inflammatory bowel disease (IBD) like Colitis Ulcerosa and Crohn’s disease.

    If you are interested in knowing more about Salovum, you are welcome to contact POA Pharma by telephone +46 31 788 0599 or email .

    Eriksson, Shafazand, Jennische and Lange, Effect of Antisecretory Factor in Ulcerative Colitis on Histological and Laborative Outcome: A short Period Clinical Trial, Scand J Gastroenterol, 2003; 10:1045-1049.

    Björck, Bosaeus, Ek, Jennische, Lönnroth, Johansson and Lange, Food induced stimulation of the antisecretory factor can improve symptoms in human inflammatory bowel disease: A study of a concept, Gut, 2000; 46:824-829.

    Hanner, Jennische and Lange, Antisecretory Factor: A clinical innovation in Ménière’s disease?, Acta Otolaryngol, 2003; 123:779-780.

    Zaman, Mannan, Lange, Lönnroth and Hanson, B221, a medical food containing antisecretory factor reduces child diarrhoea: a placebo controlled trial, Acta Paediatrica Scandinavia 96:1655-1659, 2007.

    Leave a reply →